PTSD

Latest News

TSND-201 Receives Breakthrough Therapy Designation From FDA for PTSD
TSND-201 Receives Breakthrough Therapy Designation From FDA for PTSD

July 10th 2025

Transcend Therapeutic announces breakthrough therapy designation for TSND-201 for treating PTSD.

Matthew Girgenti, PhD
Scientists Find Cellular Brain Changes Tied to PTSD

July 1st 2025

AI
AI and Augmented Reality: A Transdiagnostic Tool for Real-World Function

June 26th 2025

bipolar
Diagnosis in Bipolar Disorder: Dealing With Comorbidity

May 13th 2025

pills
April in Review: Updates on the Psychiatric Treatment Pipeline

April 30th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.